Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize
Not yet recruitingOBSERVATIONAL
Enrollment
238
Participants
Timeline
Start Date
December 1, 2025
Primary Completion Date
April 1, 2027
Study Completion Date
July 1, 2027
Conditions
Diabete Mellitus
Trial Locations (1)
Unknown
Assiut university, Asyut
All Listed Sponsors
lead
Assiut University
OTHER
NCT07204782 - Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize | Biotech Hunter | Biotech Hunter